Non-infectious Uveitis Affecting the Posterior Segment of the Eye research hub

Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye.

This study is looking at a new treatment called ILUVIEN® for children and teenagers aged 6-17 with a specific type of eye swelling called uveitis. We want to see how safe and effective this tiny eye implant is at reducing swelling and improving eyesight.